Lithium hydroxide, monohydrate → HCID 56670144, compound
Reaction equation
C[O:2][C:3](=[O:28])[CH2:4][CH2:5][N:6]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[N:8]([CH2:15][C:16]2[CH:17]=[CH:18][CH:19]=[C:20]3[C:24]=2[N:23]([CH3:25])[C:22]([CH3:26])=[CH:21]3)[C:7]1=[O:27].O.[OH-].[Li+]>C1COCC1.O>[CH3:25][N:23]1[C:24]2[C:20](=[CH:19][CH:18]=[CH:17][C:16]=2[CH2:15][N:8]2[C:9]3[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=3[N:6]([CH2:5][CH2:4][C:3]([OH:28])=[O:2])[C:7]2=[O:27])[CH:21]=[C:22]1[CH3:26]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a stirred solution of 3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid methyl ester (90 mg, 0.24 mmol) in THF (3 ml) and water (0.5 ml) was added lithium hydroxide monohydrate (15 mg, 0.36 mmol). The reaction was stirred for 0.5 h and concentrated to low volume. The remaining residue was diluted with water and acetic acid (0.3 ml). The resulting suspension was stirred at ambient temperature over night. The precipitate was collected via filtration, washed with water and then suspended in 1:1 acetonitrile/water. The solid precipitate was isolated via filtration and dried to give 65 mg (87%) of 3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid. LCMS (ESMS): m/z 364.41 (M+H).
Workup
- concentrationconcentrated to low volume
- additionThe remaining residue was diluted with water and acetic acid (0.3 ml)
- stirringThe resulting suspension was stirred at ambient temperature over night
- filtrationThe precipitate was collected via filtration
- washwashed with water
- customThe solid precipitate was isolated via filtration
- customdried
Sources & evidence
- ORD record
- ord-eee7f539ed184527be5ca86d06c9aff7
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09150556B2
Reaction notes
Loading…